Wird geladen...
Long-term use of interferon-β in multiple sclerosis increases Vδ1(−)Vδ2(−)Vγ9(−) γδ T cells that are associated with a better outcome
BACKGROUND: We previously reported that Vδ2(+)Vγ9(+) γδ T cells were significantly decreased in multiple sclerosis (MS) patients without disease-modifying therapies (untreated MS) and were negatively correlated with Expanded Disability Status Scale (EDSS) scores, suggesting protective roles of Vδ2(+...
Gespeichert in:
| Veröffentlicht in: | J Neuroinflammation |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6743159/ https://ncbi.nlm.nih.gov/pubmed/31519178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-019-1574-5 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|